Multicriteria decision analysis and core values for enhancing vaccine-related decision-making

Science Translational Medicine  29 Jun 2016:
Vol. 8, Issue 345, pp. 345ps14
DOI: 10.1126/scitranslmed.aaf0756

You are currently viewing the abstract.

View Full Text


Vaccines have the potential to transform the health of all individuals and to reduce the health inequality between rich and poor countries. However, to achieve these goals, it is no longer sufficient to prioritize vaccine development using cost-effectiveness as the sole indicator. During a symposium entitled “Mission Grand Convergence—The Role of Vaccines,” held in Siena, Italy, in July 2015, key stakeholders agreed that the prioritization of vaccine development and deployment must use multicriteria decision-making based on the following core concepts: (i) mortality and severity of the disease, (ii) vaccine safety considerations, and (iii) economic evaluation that captures the full benefits of vaccination.

View Full Text